Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Article in Alzheimer's Research & Therapy (February 2023)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review
Article in Frontiers in Neuroscience (September 2022)
Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease
Article in JAMA Network Open (September 2021)